Formulation and Evaluation of Finasteride Loaded Nanoparticles Based Topical Gel for the Management of drogenetic Alopecia
Abstract
The present study aimed to develop and evaluate Finasteride-loaded nanostructured lipid carriers (NLCs) for topical delivery in the management of androgenetic alopecia. Finasteride, a 5α-reductase inhibitor, is widely used for treatment but is associated with systemic side effects when administered orally. To overcome this limitation, NLCs were prepared using Compritol 888 ATO and oleic acid by hot emulsification followed by ultrasonication technique. The optimized formulation exhibited a mean particle size of 248.2 nm and entrapment efficiency of 84.37%. The in vitro drug release study demonstrated a biphasic release pattern with sustained drug release up to 6 h. The optimized NLCs were further incorporated into Carbopol 940 gel for topical application. The gel showed satisfactory pH (6.8), spread ability, viscosity, and drug content (97.45%). The results suggest that Finasteride-loaded NLC gel may serve as a promising topical delivery system with improved localization, sustained release, and potential reduction in systemic side effects.
Keywords: Finasteride; Androgenetic alopecia; Nanostructured lipid carriers; Topical gel; 5α-reductase inhibitor; Controlled release
Keywords:
Nanostructured lipid carriers (NLCs), androgenetic alopecia, Finasteride /formulationsDOI
https://doi.org/10.22270/jddt.v16i7.7828References
1. Kaufman KD. Androgens and alopecia. Mol Cell Endocrinol. 2002;198(1-2):89-95. https://doi.org/10.1016/S0303-7207(02)00372-6 PMid:12573818
2. Trüeb RM. Molecular mechanisms of androgenetic alopecia. Exp Gerontol. 2002;37(8-9):981-990. https://doi.org/10.1016/S0531-5565(02)00093-1 PMid:12213548
3. Price VH. Treatment of hair loss. N Engl J Med. 1999;341(13):964-973. https://doi.org/10.1056/NEJM199909233411307 PMid:10498493
4. Gupta AK, Charrette A. The efficacy and safety of 5-alpha reductase inhibitors in androgenetic alopecia. Expert Opin Drug Saf. 2014;13(10):1411-1420.
5. Müller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm. 2002;242(1-2):121-128. https://doi.org/10.1016/S0378-5173(02)00180-1 PMid:12176234
6. Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366(1-2):170-184. https://doi.org/10.1016/j.ijpharm.2008.10.003 PMid:18992314
7. Wissing SA, Kayser O, Müller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev. 2004;56(9):1257-1272. https://doi.org/10.1016/j.addr.2003.12.002 PMid:15109768
8. Souto EB, Müller RH. Cosmetic features and applications of lipid nanoparticles. Int J Cosmet Sci. 2008;30(3):157-165. https://doi.org/10.1111/j.1468-2494.2008.00433.x PMid:18452432
9. Shah R, Eldridge D, Palombo E, Harding I. Lipid Nanoparticles: Production, Characterization and Stability. Springer; 2015. https://doi.org/10.1007/978-3-319-10711-0
10. Müller RH, Petersen RD, Hommoss A, Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev. 2007;59(6):522-530. https://doi.org/10.1016/j.addr.2007.04.012 PMid:17602783
11. Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366(1-2):170-184. https://doi.org/10.1016/j.ijpharm.2008.10.003 PMid:18992314
12. Giron D. Applications of thermal analysis and coupled techniques in pharmaceutical industry. J Therm Anal Calorim. 2002;68(2):335-357. https://doi.org/10.1023/A:1016015113795
13. Silverstein RM, Webster FX, Kiemle DJ, Bryce DL. Spectrometric Identification of Organic Compounds. 8th ed. Hoboken: John Wiley & Sons; 2014.
14. Giron D. Applications of thermal analysis and coupled techniques in pharmaceutical industry. J Therm Anal Calorim. 2002;68(2):335-357. https://doi.org/10.1023/A:1016015113795
15. Müller RH, Petersen RD, Hommoss A, Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev. 2007;59(6):522-530. https://doi.org/10.1016/j.addr.2007.04.012 PMid:17602783
16. Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366(1-2):170-184. https://doi.org/10.1016/j.ijpharm.2008.10.003 PMid:18992314
17. Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47(2-3):165-196. https://doi.org/10.1016/S0169-409X(01)00105-3 PMid:11311991
18. Sinko PJ. Martin’s Physical Pharmacy and Pharmaceutical Sciences. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2011.
19. Shah R, Eldridge D, Palombo E, Harding I. Lipid Nanoparticles: Production, Characterization and Stability. Cham: Springer; 2015. https://doi.org/10.1007/978-3-319-10711-0
20. Lachman L, Lieberman HA, Kanig JL. The Theory and Practice of Industrial Pharmacy. 3rd ed. Philadelphia: Lea & Febiger; 1986.
21. Garg A, Aggarwal D, Garg S, Singla AK. Spreading of semisolid formulations: an update. Pharm Technol. 2002;26(9):84-105.
22. Martin A. Physical Pharmacy. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2006.
23. Sinko PJ. Martin’s Physical Pharmacy and Pharmaceutical Sciences. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2011.
24. Jain A, Gautam SP, Gupta Y, Khambete H, Jain S. Development and characterization of topical gel formulations. Int J Pharm Sci Res. 2010;1(2):54-63.
25. Kalia YN, Guy RH. Modeling transdermal drug release. Adv Drug Deliv Rev. 2001;48(2-3):159-172. https://doi.org/10.1016/S0169-409X(01)00113-2 PMid:11369080
26. Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 2010;67(3):217-223.
27. ICH. Q1A(R2): Stability Testing of New Drug Substances and Products. International Conference on Harmonisation; 2003.
Published
Abstract Display: 0 
PDF Downloads: 0 PDF Downloads: 0 How to Cite
Issue
Section
Copyright (c) 2026 Atharv S. Jawanjal , Sandeep Atram
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.